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Rapid research needs appraisal for outbreaks protocol 
Background information 
The UK Public Health Rapid Support Team (PHRST)  
The UK PHRST is a UK Government funded initiative jointly run by Public Health England 
(PHE) and an academic partnership consisting the London School of Hygiene and Tropical 
Medicine, the University of Oxford and King’s College London. The UK PHRST monitors 
infectious diseases globally, this team of trained experts are ready to respond to urgent 
requests from countries receiving Official development assistance (ODA) from the UK 
Government, from the WHO and the Global Outbreak and Response Network (GOARN). The 
team will work together with local health providers to prevent local disease outbreaks from 
becoming global epidemics. In addition to responding to outbreaks, the UK PHRST will 
conduct research to improve the response to epidemics in the future and to build the local 
capacity within low and middle income countries (LMICs) and for public health reservists in 
the UK through training modules. 
The need for a Rapid research needs appraisal 
The evidence for making decisions in the midst of an epidemic is often extremely limited, 
with decisions often based on expert opinion. The barriers for conducting research during 
epidemics includes the unpredictability, short timeframes and challenging logistics of 
running field research in resource limited countries. Research is often the lowest priority 
during an epidemic, and if there is an opportunity to perform research, the priorities and 
research gaps need to be identified as quickly as possible. The aim of this work is to perform 
a rapid scoping exercise to identify the key knowledge and research gaps, in order to help 
identify and prioritise research questions that need addressing. The premise, if possible is to 
take advantage of time differences across the globe to enable the rapid appraisal of existing 
evidence to be conducted over five days. 
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Project aims and objective: 
The aim is to develop a rigorous, transparent and replicable methodology for researchers 
and clinicians to conduct an accelerated evidence review at the early stages of an epidemic 
to identify key knowledge gaps to prioritise patient-centred clinical research.  
Key objectives: 
 A written protocol for completing a rigorous evidence review within 5 days of recognition 
of the need for a rapid research needs appraisal in response to an outbreak. 
 Development of a model where global partnerships, and efficient use of teams in 
different global time-zones, are optimised for rapid implementation of the research 
needs appraisal. 
 Evaluation of the methodology using an outbreak scenario. 
 Publication of final protocol on the conduct of a rapid research needs appraisal. 
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This protocol was produced in a collaborative effort by the Epidemic Disease Research 
Group and UK Rapid Support Team at the Centre for Tropical Medicine and Global Health at 
University of Oxford, Evidence Aid and Cochrane Response.  
Authors: Louise Sigfrid, Alex Salam, Catrin Moore, Rachel Marshall, Nicola Maayan, 
Charlotte Pestridge, Candyce Hamel, Chantelle Garritty, Karla Soares-Weiser, Mike Clarke 
and Peter Horby.  
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1. Background 
Systematic reviews might require time and resources that are not available in a rapidly 
emerging area such as a (re-) emerging infectious disease outbreak. Even rapid evidence 
reviews often takes weeks to months to complete. At the initial stages of an outbreak 
researchers, policy makers and funders are in the need to rapidly identify gaps in evidence 
and knowledge to inform and prioritise rapid clinical and public health research responses. 
This document presents a methodology for carrying out a rapid research needs appraisal 
(RRNA) within a limited time-frame. The aim is to review existing evidence covering a range 
of areas to identify gaps in knowledge and evidence. The results will be used to rapidly 
inform research priorities with a focus on clinical research to advance diagnostics, clinical 
management, integrated with public health responses. 
The protocol contains standardised pre-defined tables that are designed to be generic and 
to capture clinical data relevant for rapid, clinical research responses. These can be rapidly 
reviewed and modified if needed, depending on the nature of each outbreak.  If an evidence 
management system is used, the protocol can be pre-programmed into the system, then 
modified slightly if required in response to an outbreak. 
The methodology is designed to be used for emerging outbreaks, where the clinical 
evidence base is expected to be limited. The aim of the methodology is to identify gaps in 
knowledge and evidence to inform clinical research priorities in response to emerging 
outbreaks. 
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2. Management and responsibilities 
 
The decision to carry out a rapid research needs appraisal (RRNA) will be taken by a steering 
group comprising of infectious diseases specialists, clinical researchers and content experts 
as relevant to the outbreak scenario. Once the steering has taken the decision to undertake 
a rapid research needs appraisal, the steering group will convene a coordinating team that 
will coordinate the process as outlines in Figure 1. It is recommended that the systematic 
evidence search is carried out by an experienced health information specialist, and that the 
screening of papers for inclusion and data extraction is carried out by a minimum of three 
people with experience in systematic reviews to ensure rigour and quality. The number of 
systematic reviewers can be scaled up depending on the nature of the outbreak and the 
volume of evidence identified. Use of a systematic review software will enable scaling up of 
resources as required depending on volume of evidence retrieved, and allow processes such 
as screening and data extraction to be done in parallel by several reviewers.  Resources can 
also be scaled up by use of global teams of systematic reviewers and efficient use of time-
zones.  
 
The method is designed to be used to rapidly synthesis existing evidence to identify 
knowledge gaps in response to a (re-) emerging infectious disease outbreak. It is expected 
that the volume of existing clinical relevant evidence will be limited. The outcome of the 
rapid research needs appraisal will be a summary of existing clinical evidence, which will 
highlight where gaps in knowledge and evidence exists and inform clinical research 
priorities.  
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 DAY 1                            DAY 2                                               DAY 3 – 5 
 
 
Figure 1. The rapid research needs appraisal process 
RRNA = Rapid research needs appraisal, CT = Coordinating team 
 
 
2.1 Trigger for conducting a rapid research needs appraisal 
The trigger to carry out a rapid, research needs appraisal will be in response to an emerging 
outbreak. It will be based on information from global outbreak reports or risk assessments 
produced by the UK Rapid Support Team, CDC, ECDC, WHO or in response to a request from 
local stakeholders, e.g. clinicians working in an affected region.  This information will be 
reviewed by a steering group including infectious disease and clinical research experts who 
will decide whether there is a need for an RRNA (section 2.2).  
SG convenes the 
coordinating  team (CT) 
= Day 1
CT alerts the information 
specialist and systematic 
review team/s 
Protocol reviewed
CT submitts the protocol 
to the information 
specialist and systematic 
review team/s
Evidence search and full 
text articles retrieved by 
information specialist
Systematic review team 
programs the software 
used for the screening 
and data extraction
Screening of titles and 
abstracts by systematic 
review team/s
Screening of full text 
articles and data 
extraction by systematic 
review team/s
Systematic review 
team/s submits data 
outcome tables to the CT.
The CT collates the final 
report and submits to the 
steering group
Steering group (SG) 
decides to undertake 
RRNA 
Trigger 
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2.2 Rapid research needs appraisal steering group  
If a trigger is identified or a request for a rapid research needs appraisal received by the 
steering group (RRNA SG), it is the steering group’s responsibility to review the information 
in a timely manner (Table 1). The RRNA SG will review the information available and consult 
with content experts as appropriate depending on the nature of the outbreak. The decision 
to undertake a RRNA will be informed by risk assessments produced by organisations as 
described in section 2.1 and consultations with content experts as appropriate depending 
on each outbreak. An RRNA will only be undertaken if after consultations it is deemed that 
there is insufficient evidence available to base an informed decision on clinical research 
prioritise in response to the outbreak. 
To enable an informed decision about carrying out a rapid, research needs appraisal it is 
recommended that the steering group consists of at least one: 
 Infectious disease specialist  
 Clinical researcher 
 Additional specialists as appropriate depending on the nature of the outbreak 
 
Depending on the assessment, the decision taken will be either that: 
 
1. There is need for an RRNA  
2. There is no need for an RRNA 
3. The information is insufficient at this moment in time. The need for a 
RRNA will be re-assessed within a set time frame.  
 
When the decision is taken to start a RRNA this is Day 1 of the RRNA process. The RRNA SG 
will then convene a coordinating team. Depending on the structure of the organisation and 
resources the steering group and coordinating group can be the same. 
 
 
Steering group responsibilities  
To risk assess the emerging outbreak and the need for a RRNA 
To consult with additional content experts as appropriate to assess 
the situation and inform the decision to undertake a RRNA 
If a decision is taken to carry out a RRNA to convene the 
coordinating team the same day to start the process (= Day 1). 
Table 1. Responsibilities of the steering group 
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2.3 Rapid research needs appraisal coordinating team  
The rapid research needs appraisal coordinating team (RRN CT) is responsible for 
coordinating the rapid needs appraisal process from notification of the need for a RRNA 
from the steering group, through to completion (Table 2).  
 
Composition of the coordinating team: 
 An infectious disease specialist 
 Additional content experts as required depending on the nature of the outbreak 
 Researcher with experience in systematic evidence reviews 
 Administrative support  
 
The RRN CT will meet on Day 1 to: 
 Alert the information specialist and systematic review team/s of the need for a 
RRNA. 
 Review the protocol and identify if any adaptions are needed depending on the 
nature of the outbreak. 
 Finalise and send the protocol together with a brief overview of the situation and 
clinical background information to the information specialist and systematic review 
team/s by end of Day 1. 
 Provide a verbal briefing to the information specialist and systematic review team/s. 
 Advise on if specific language expertise might be required in regards to the location 
of the outbreak.  
 Register the protocol on the Open Science Framework. 
 
During the process the coordinating team will be at hand to answer clinical or content 
specific queries from the systematic review teams. 
 
 
Responsibilities of the coordinating team 
Day 1 To alert the information specialist and systematic review team/s of the need 
for a RRNA  
To review the protocol and make any amendments needed depending on the 
nature of the outbreak  
To submit the final protocol with amendments clearly highlighted to the 
information specialist and systematic review team/s 
To provide a brief overview of the situation and clinical background report to 
the information specialist and systematic review team/s 
Day 2 - 4 To be on stand-by to provide clinical or content specific advice as required 
To monitor the progress and help finding solutions to any unexpected issues 
Day 5 To collate the data outcome tables and notes from the systematic review 
team/s into the final report and submit to the steering group 
Table 2. Responsibilities of the coordinating team 
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2.4 Information specialist 
An experienced information specialist should be identified and engaged in the process in 
advance so they are prepared to respond when the need for an RNNA arises. 
The information specialist will be responsible for carrying out a systematic evidence search 
across all domain question as soon as the CT has reviewed and made any necessary 
amendments to the protocol. They will then forward the search results, after de-duplication 
of records, together with full text articles to the systematic review team/s. Responsibilities 
of the information specialist (Table 3). 
 
Information specialist responsibilities  
Day 1 - 2 Carry out a systematic evidence search across all domains as soon as they 
receive the final protocol from the coordinating team (Day 1-2) 
De-duplicate records and retrieve full text articles using Endnote 
Upload the search results as an Endnote file with the search results to 
Dropbox as soon as completed. Sends out an alert to all that it is uploaded. 
Retrieves full text articles through Endnote and University library access. 
Uploads the Endnote library with full text papers to Dropbox. Sends out an 
alert that this is completed and uploaded. 
Day 2-3 Once the reviewers have screened and included papers they will send a list 
of included papers without the full text paper retrieved to the information 
specialist. The information specialist will try to retrieve these manually 
through their University library access. Full text papers found will be 
uploaded as pdf’s to Dropbox and the reviewers alerted when completed. 
If the full text papers are still not accessible a note will be made, including 
the paper bibliography by the review team and submitted with the data 
outcome table to be included in the final report. 
Table 3. Responsibilities of the information specialist 
 
2.5 Systematic review team 
To ensure rigour and quality it is essential that the systematic review team/s involved are 
trained in the methodology and in screening and data extraction in advance. Use of 
systematic review software is recommended to enable systematic reviewers in different 
locations globally to work on the screening and data extraction process in parallel and for 
audit. However it is not a requirement. 
A minimum of two systematic reviewers are essential for quality. Depending on the volume 
of evidence retrieved the number of systematic reviewers can be scaled up. Responsibilities 
of the systematic review team/s (Table 4). 
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The systematic review team/s will be notified about the need for carrying out a RRNA in 
response to a (re-) emerging outbreak by the RRNA coordinating team on Day 1. The review 
teams will be sent the protocol after review by the coordinating team by the end of Day 1. 
The coordinating team will also provide a brief with information about the outbreak and 
pathogen involved in writing and by phone or Skype. The coordinating team will be available 
to answer questions during the screening and data extraction process. 
The systematic review teams will receive the search results from the information specialist 
by day 2. The team/s will then screen the titles and abstracts, full text papers, and extract 
the data into the data extraction template (Table 10). The systematic review team/s will 
send the completed data outcome templates to the coordinating team by mid-day on day 5. 
Responsibilities of the systematic review team 
Day 1 Once the alert has been received from the CT to identify a minimum of two 
systematic reviewers with capacity to carry out the screening and data 
extraction  
When the final protocol is received to make the necessary amendments to the 
Systematic review software pre-programmed protocol 
Day 1-2  Upload the Endnote search result file that the information specialist has 
uploaded to Dropbox into Distiller.  
Screen titles and abstracts  
Once the Endnote library with full text papers have been uploaded to Dropbox 
by the information specialist the systematic review team will upload it to 
Distiller. 
Papers included where there is no full text paper retrieved will be listed. This 
list will be submitted to the information specialist for manual searching of the 
papers. Once the manual search is completed the information specialist will 
upload the full text papers to the Dropbox folder. 
If resources allows, start screening full text papers in parallel 
Day 3 - 4 Complete screening of titles and abstracts  
Complete screening of full text papers in parallel 
 
Start data extraction in parallel  
 
Day 5 Complete data extraction  
Submit the data outcome tables for all domains to the coordinating team 
Table 4. Responsibilities of the systematic review team 
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 Level of expertise needed  
Minimum of two experienced systematic reviewer  
Depending on the outbreak relevant language expertise 
might be required  
Table 5. Systematic review expertise 
 
Systematic review software 
It is important to identify and engage organisations with systematic review expertise in 
advance, so they are prepared to respond rapidly to an emerging outbreak. Global teams of 
systematic reviewers can be identified and engaged in advance, to ensure capacity, 
contingency and to enable effective use of time-zones if required depending on the type of 
the outbreak. To optimise resources, allow processes to run in parallel without the need for 
handovers, and for rapid scaling up of resources if needed, it is advised to use a Systematic 
review software accessible by all teams. Using a systematic review software also allows 
continuous monitoring of progress, rapid identification of issues and audit.  
 
Reporting responsibilities 
The systematic review team/s are responsible for submitting the completed data outcome 
tables with any associated brief comments or notes as appropriate, by mid-day on day 5 to 
the coordinating team via e-mail. The review team will also complete and submit the 
PRISMA diagram, including number of papers screened and numbers excluded at each step 
of the screening process.  
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3. Protocol 
The figure below outlines the overall methodology and process over the five days, from the 
decision is taken to start the rapid research needs appraisal process (Day 1) through to the 
final report submission on Day 5 (Figure 2). The protocol is described in detail in the 
following section. On day 1 the coordinating team will review this protocol and make any 
amendments as required depending on each outbreak. It is recommended to use a 
systematic review software to enable steps in the protocol to be carried out in parallel. It 
will also allow pre-programming of the protocol in advance. 
 
 
Figure 2. Rapid research needs appraisal process  
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Outbreak scenario 
Description of the outbreak to be added for each outbreak, using risk assessments published 
by the Centre for Disease Control and Prevention (CDC), the European Centre for Disease 
Prevention and Control (ECDC) or the World Health Organisation (WHO). 
                                                                        
 
15 
 
3.1 Scoping questions    
It is important to make sure the scoping questions are well defined and specific to the 
emerging threat. The RRNA coordinating team will review the pre-defined questions for 
each domain and modify if needed, depending on each outbreak on Day 1. The domain 
template has been developed as a standard template to cover key clinical infectious disease 
research questions (Table 6). This template will be reviewed by the coordinating team for 
each outbreak scenario and modified if appropriate on Day 1 then submitted to the 
information specialist and systematic review teams.  
Domain Question(s) Population  
Clinical 
phenotype and 
natural history of 
disease 
What are the signs and symptoms of the 
disease? 
What are the laboratory (haematology, 
biochemistry, coagulation etc) features of 
disease? 
Which constellations of clinical features 
distinguish disease from differential diagnoses?  
Are there distinct clinical syndromes amenable 
to staging/grading? 
Does asymptomatic infection occur? 
What is the mortality rate? 
Neonates 
Infants 
Children 
Adults 
Elderly 
Pregnant 
Transmission  What is the incubation period of the disease? 
What are the routes of transmission? 
What are the infective body fluids? When and 
how long are they infectious for? 
Prevention How effective is vaccination (if it exists) at 
preventing disease?  
What are the side effects of vaccination? 
How effective is drug prophylaxis (if it exists) at 
preventing disease? 
How effective is post-exposure drug prophylaxis 
(if it exists) at preventing disease? 
What are the side effects of drug prophylaxis? 
Diagnostics What is the sensitivity and specificity of different 
diagnostic tests? In different bodily fluids (e.g., 
blood, CSF, urine)? 
Immune 
response  
What is the serological response to infection? 
Drug therapy 
effect 
What is the effect of drug therapy on: 
- length of hospital stay? 
- complications 
- mortality rate? 
What is the effect of different doses, routes and 
frequencies of drug therapy on the response? 
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What are side effects of drug therapy? Breastfeeding 
Immunosuppressed  
Malnourished 
Comorbidities  
Supportive care 
(e.g., 
electrolytes, 
fluids) 
What is the effect of supportive care on: 
- length of hospital stay? 
- Complications 
- mortality rate? 
What is the effect of different doses, routes and 
frequencies of supportive therapy on the 
response? 
What are the side effects of supportive therapy 
 
Risk factors What are the risk factors for disease? 
What are the risk factors for severe disease? 
What are the risk factors for mortality? 
What are the risk factors for long term 
complications/sequela? 
 
Table 6. The domain questions to be covered  
The scoping question criteria should be defined using (PI (E) COs): Population, Interventions, 
Exposure, Comparator, Outcomes. 
The RRNA coordinating team will review the template and modify as appropriate depending on each 
outbreak on day 1. 
 
3.2 Evidence search 
Since the RRNA will be used for emerging infectious disease outbreaks where there might be 
very limited evidence published prior to the outbreak, the search needs to be inclusive. 
Therefore, all types of studies published in peer reviewed publications, grey literature and 
unpublished data might be considered to be included, depending on each specific outbreak. 
The table below will be used as a template and reviewed by the coordinating team for each 
RRNA request and modified/restricted as appropriate on Day 1.   
 
The evidence search should be carried out centrally across all domains by an experienced 
information specialist. The information specialist will carry out the search once the final 
protocol with the specified search strategy has been received from the coordinating team, 
by Day 1 - 2.  It is recommended that the information specialist is assigned to a University 
library to enable automatic uploading of full text papers into Endnote.  
 
The information specialist will send the search results as an Endnote file with full text 
articles to the systematic review team/s by Day 2.  
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Sources of evidence 
The main databases to be covered by the search are listed in table 7.  
These will be reviewed and modified as appropriate depending on the nature of the 
outbreak by the coordinating team on day 1.   
 
Data bases 
PubMed, Embase, Cochrane Library, 
DARE, Epistomonikos, Prospero 
Clinical trial registries (clinicaltrials.gov, 
ISRCTN registry) 
Grey literature e.g.: WHO, CDC, ECDC 
Table 7. Databases to be covered 
 
Search restrictions 
To be defined for each outbreak. 
 
Study designs to include 
 
7 Case series 
8 Case reports 
9 Conference abstracts 
 
Table 8 
The table shows the study types to be included and the hierarchy of evidence. 
 
Retrieving full text articles 
The information specialist will retrieve the full text articles through Endnote and University 
library access. The information specialist will send the Endnote library will upload the search 
results to Dropbox and send an alert to all teams. The information specialist will then 
retrieve the full text papers using the Endnote automatic retrieval function, and once 
completed, upload the library to Dropbox and send out another alert. Once the screeners 
have included papers, they will send a list of included papers where the full text article is not 
available to the information specialist, who will then carry out a manual search for these. 
Papers retrieved from this search will also be uploaded to Dropbox and an alert sent to all 
Hierarchy  Study designs to always include 
1 Systematic reviews and meta-analyses 
 
2 Randomised controlled trials (RCT)  
 
3  Other controlled studies (e.g. non-RCT, randomized cross-over studies) 
 
4 Cohort studies incl. before and after studies (prospective/retrospective) 
 
5 Case-control studies 
 
6 Cross-sectional studies (including audits) 
 
                                                                        
 
18 
 
teams when completed. Papers that are not identified after the manual search will be noted 
in the final report. 
 
After screening of titles and abstracts are completed, the systematic reviewers will send a 
list with included papers not yet retrieved to the information specialist. The information 
specialist will manually search for these. If at this stage full text papers are still not 
accessible, a note including the details of the paper, should be made in the report. 
 
3.3 Screening 
Once the information specialist has completed the evidence search, it will be sent to the 
systematic review team/s as an Endnote library (see section above). Once received the 
systematic review team will upload the file to Distiller and send an alert to all teams that it 
has been completed to start screening. The review team uploading the library to Distiller 
depends on the time of the day the search is completed. The review teams will organise this 
internally.  
The systematic review team will then start the screening of abstract and titles. To ensure 
rigour and quality there needs to be a minimum of two systematic reviewers. As it is 
expected that there will be limited evidence published it is key to ensure that the screening 
strategy is rigorous as well as inclusive. If they have access to a systematic review software, 
this means that once the Endnote file is uploaded work can be ongoing in parallel, and it is 
easy to keep track of tasks that has been done or need doing.  
Once the Endnote library with full text papers are uploaded to Dropbox by the information 
specialist, the review teams will upload it to Distiller. As above, the review team responsible 
for this depends on the time of the day and will be organised by the review teams internally. 
 
 Title and abstracts will be screened for inclusion by one experienced systematic 
reviewer. A second experienced systematic reviewer will screen the articles excluded 
by the first reviewer for inclusion.  Any disagreements will be included. 
 
 Papers include where there is no full text paper retrieved by Endnote, will be listed. 
This list will be sent to the information specialist via e-mail for a manual search of 
the papers. Once the manual search is complete the information specialist will 
upload additional papers retrieved manually to Dropbox and alert the review teams. 
If it is not possible to obtain and assess a full text article within the time and 
resources available, a note will be made in the report, and these papers will be listed 
with full bibliography in the final report.  
 
 Full text articles will be screened by two reviewers and disagreements checked by a 
third reviewer with experience in infectious diseases for consensus. 
 
 Depending on the nature of the outbreak, if it is expected that key evidence has 
been published in a language other than English, then a reviewer or a review team 
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from that region or with the specific language skills will be ideal to engage at the 
start of the process whenever possible.  
 
 In general, for papers in languages other than English, if possible a reviewer with the 
required language expertise should review and extract the data, especially if it is a 
high quality paper. If it is not possible to identify a reviewer with required language 
skills a note should be made in the report, and any papers not extracted listed with 
full bibliography.  
 
Inclusions and exclusions 
As the volume of evidence is expected to be limited, and it is therefore important to ensure 
all relevant evidence is included, there will not be many restrictions on the inclusions. The 
focus is on clinical studies in humans. Animal studies will be excluded. The inclusion and 
exclusion criteria will be reviewed and adapted as appropriate depending on each outbreak. 
 
Inclusion criteria Exclusion criteria 
Clinical research Animal studies 
No language restrictions Cell culture studies 
 Non-clinical studies 
Table 9. Inclusion and exclusion criteria 
 
3.4 Data extraction 
The aim of the rapid evidence appraisal is to identify gaps in knowledge to inform 
prioritisations of rapid research responses. With limited time the data extraction needs to 
be limited to essential data.  Data will be extracted into a pre-defined outcomes table (Table 
10).  
 Data will be extracted into the pre-defined data outcomes template by one 
experienced systematic reviewer. 
 A second reviewer will check 10% of all data and 100% of the numeric data. 
 Additional brief notes in bullet style format (linked to relevant papers) to be added 
as appropriate under the data outcome table. 
 Data from case series, case reports and conference abstracts will only be extracted if 
no higher level of evidence for that domain questions identified. 
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Table 10. Data outcome table for the data extraction  
The table shows the data to be extracted into the data outcome table. If a paper is covering 
more than one outcome, enter data as appropriate in separate rows. If several papers are 
covering the same study, or same cohort, enter all data in separate rows and make a note. 
The result section should report primary and secondary outcome statistical data. 
Data covering study design, setting, n numbers and PI (E) COs: Population, Interventions, 
Exposure, Comparator, Outcomes. 
*Data reporting should include description of the populations covered, including: 
 Male/Females and age range 
 Neonates/infants/children/young people and age range 
 Pregnant women/Post-partum/breastfeeding women 
 People who are immunosuppressed by illness or medication 
 Malnutrition 
 Comorbidities 
 
3.5. Reporting the results 
The aim of the rapid evidence appraisal is to review and rapidly synthesis minimum data sets from 
existing evidence to identify where there are gaps in knowledge. This information will be used to 
inform research prioritise for rapid, clinical research responses. 
Bibliography 
(Author, Title, 
Journal, Year) 
Study 
setting
Study 
time-
frame
Study 
objectives
Study 
design
Populations/ 
demographics
N 
numbers
Population 
problem
Description of 
intervention, 
exposure
Comparator Description 
of 
outcomes 
Results, 
incl. 
adverse 
events
Key 
limitations
Domain
Month, 
year
Male/Females and       
age range, 
Neonates/infants/ 
children/young        
people and age range;          
Pregnant women/      
Post-partum/  
breastfeeding; 
Immunosuppression    
(by medication, age 
and/or illness);          
Malnutrition; 
Comorbidities
Total 
and per 
group
E.g. 
pathogen/s, 
medical 
management, 
treatment, 
vaccination
Key 
limitations 
reported 
Smith, Lassa 
fever, Plos 
Med, 2017
Sierra 
Leone
01/201
3 to 
12/201
3
Clinical 
study 
evaluating 
use of….
Jonnes, Lassa 
fever, Lancet, 
2016
Sierra 
Leone
01/201
3 to 
12/201
4
Long term 
follow up 
of 
Notes:
                                                                        
 
21 
 
The systematic review teams are responsible for submitting the completed data outcome tables 
generated to the coordinating team by mid-day on Day 5. The coordinating team are responsible for 
collating the results from all domains and systematic review team/s into the final report. The 
coordinating team is also responsible for submitting the final report to the steering group by the end 
of Day 5. Once the steering group has reviewed the report and any queries has been followed and 
the report approved by the steering group, it will be circulated to the systematic review teams and 
can at this stage be shared with external stakeholders. The steering group will use the report to 
inform research prioritisation decisions, through discussions with external stakeholders and content 
experts as appropriate. 
Final report template: 
 Title 
 
 Background:  
 Brief overview of the outbreak and data available 
  Aims and objective of the RRNA  
 
 Results 
 PRISMA flow diagram  
 The data outcome tables submitted by the review team/s for all 
domains and associated notes 
 Associated notes and comments, including papers included, but were 
data were not extracted due to e.g. language other than English, or 
the full text paper not accessible. 
 
 Methodology: 
 Teams and experts involved  
 Abbreviated methods section to include a checklist of items 
 Search protocol and search terms 
 
3.6 Quality control 
Quality will be maintained by ensuring that the organisations and teams involved have 
previous necessary experience as described above, and the resources needed. The protocol 
will be reviewed for each outbreak by experts in infectious diseases, clinical research and by 
consultation with content experts as required, and modified as appropriate. The 
information specialist and systematic review teams will be engaged and trained in the 
protocol in advance and notified as soon as the decision for undertaking an RRNA is made. 
Ensuring that the teams have experience of systematic reviews will also ensure rigour, 
consistency and quality. The final report will be reviewed by infectious disease specialist and 
content experts, with experience relevant to the specific outbreak and clinical domain 
questions.  
